Annual Report 2021

Cancer Genomics Repository Section

Tomohisa Sudo, Azusa Takeuchi, Jun Oikawa, Tsuyuka Otsuki, Takehito Saito

Introduction

 Our section was established in June 2018 as a section of the Center for Cancer Genomics and Advanced Therapeutics (C-CAT).

The Team and What We Do

 The Section of Cancer Genomics Repository collects clinical data and genomic data from core hospitals for cancer genomic medicine, affiliated hospitals and cancer genomics laboratories that can be used for secondary purposes. C-CAT findings are created from the collected clinical data and genomic data and returned to the hospital. By March 2022, there were approximately 30,000 registered cases (Figure 1). In addition, we work on construction and management of the cancer genomics repository, a master database for cancer genomic medicine in Japan.

Figure 1. Number of registered cases

Education

 Explanatory meetings were held for those involved in the core hospitals for cancer genomic medicine and affiliated hospitals, and there was on-the-job training for new staff.

Future Prospects

 We will support the operation and system of cancer genetic testing in insurance practice. In addition, we will manage the data so that it can be used secondarily. We will also continue our efforts to ensure the C-CAT findings can be returned.